Study to Characterize the Pharmacokinetics of a Single Dose of SC Abatacept 125 mg Using the BD Autoinjector or the Prefilled Syringe
Completed · Phase 1
Conditions studied: Rheumatoid Arthritis
In brief
The primary purpose of the protocol is to describe the pharmacokinetics of a single dose of Abatacept 125 mg in Rheumatoid Arthritis patients delivered via the autoinjector device or the approved prefilled syringe.
Key facts
- Study ID
- NCT01890473
- Run by
- Bristol-Myers Squibb
- People needed
- 356
- Starts
- 2013-07-01
- Expected to finish
- 2014-11-01
- Last updated by the study team
- 2015-11-26
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Rheumatology Associates Of North Alabama, P.C. — Huntsville, Alabama, United States
- Immunoe Int'L Research Ctrs — Centennial, Colorado, United States
- Covance Cru Inc — Daytona Beach, Florida, United States
- Heartland Research Associates, Llc — Wichita, Kansas, United States
- Clinical Pharmacology Study Group — Worcester, Massachusetts, United States
- Physician Research Collaboration, Llc — Lincoln, Nebraska, United States
- Djl Research, Pllc — Charlotte, North Carolina, United States
- Wake Research Associates — Raleigh, North Carolina, United States
- Pmg Research Of Salisbury — Salisbury, North Carolina, United States
- Pmg Research Of Wilmington Llc — Wilmington, North Carolina, United States
- Community Research — Cincinnati, Ohio, United States
- Altoona Center For Clinical Research — Duncansville, Pennsylvania, United States
- Covance Clinical Research Unit Inc. — Dallas, Texas, United States
- Local Institution — San Fernando, Buenos Aires, Argentina
- Local Institution — Córdoba, Córdoba Province, Argentina
- Local Institution — Córdoba, Córdoba Province, Argentina
- Local Institution — Rosario, Santa Fe Province, Argentina
- Local Institution — San Miguel de Tucumán, Tucumán Province, Argentina
- Local Institution — Yucatán, Yucatán, Mexico
- Local Institution — Lima, Lima Province, Peru
- Local Institution — Lima, Lima Province, Peru
- Local Institution — Port Elizabeth, Eastern Cape, South Africa
- Local Institution — Pretoria, Gauteng, South Africa
- Local Institution — Pretoria, Gauteng, South Africa
- Local Institution — George, Western Cape, South Africa
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.